|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/28 | |||
| A61M 5/315 | |||
| A61K 9/00 | |||
| A61K 47/18 |
| (11) | Patento numeris | 3354280 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18161288.8 |
| Europos patento paraiškos padavimo data | 2011-10-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-08-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 390283 P | 2010-10-06 | US |
| (72) |
DIX, Daniel B., US
TANG, Xiaolin, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
|
| (54) | STABILIZED FORMULATIONS CONTAINING ANTI-INTERLEUKIN-4 RECEPTOR (IL-4R) ANTIBODIES |
| STABILIZED FORMULATIONS CONTAINING ANTI-INTERLEUKIN-4 RECEPTOR (IL-4R) ANTIBODIES |